Maleimidyl magnetic nanoplatform for facile molecular MRI.
Dan Heo, Eugene Lee, Minhee Ku, Seungyeon Hwang, Bongjune Kim, Yeonji Park, Young Han Lee, Yong-Min Huh, Seungjoo Haam, Jae-Ho Cheong, Jaemoon Yang, Jin-Suck Suh
Index: Nanotechnology 25(27) , 275102, (2014)
Full Text: HTML
Abstract
In this study, we developed the maleimidyl magnetic nanoplatform, which enables functional targeting of a biomarker-specific moiety for molecular imaging via MRI. The maleimide group of the maleimidyl magnetic nanoplatform is conjugated with a thiol group without additional crosslinkers and side products. A physicochemical analysis was conducted to verify the effectiveness of the maleimidyl magnetic nanoplatform, and the existence of the maleimidyl group was investigated using the platform. To prepare biomarker-specific MRI probes, a thiolated aptamer and peptide were immobilized onto the maleimidyl group of the maleimidyl magnetic nanoplatform. The fabricated MRI probes were applied to four cancer cell lines: HT1080, MCF7, MKN45, and HEK293T. To investigate the potential of the molecular MRI probe, the target-biomarker specificity was confirmed without serious cytotoxicity, and in vivo MRI analysis using a xenograft mouse model was demonstrated. We believe these results will be useful for fabricating molecular MRI probes for the diagnosis of cancer.
Related Compounds
Related Articles:
2014-09-26
[J. Chromatogr. A. 1361 , 265-76, (2014)]
2014-10-01
[Eur. J. Pharm. Biopharm. 88(2) , 406-14, (2014)]
2015-01-01
[Eur. J. Pharm. Biopharm. 89 , 30-9, (2015)]
2014-08-01
[J. Am. Soc. Mass Spectrom. 25(8) , 1421-40, (2014)]
2015-04-21
[Analyst 140(8) , 2785-96, (2015)]